Challenges and Opportunities for Respiratory Syncytial Virus Vaccines: 372 (Current Topics in Microbiology and Immunology) - Hardcover

9783642389184: Challenges and Opportunities for Respiratory Syncytial Virus Vaccines: 372 (Current Topics in Microbiology and Immunology)
Alle Exemplare der Ausgabe mit dieser ISBN anzeigen:
 
 
Críticas:

From the reviews:

“I enjoyed the book: as an immunologist who has spent 10 years working on RSV there were a number of novel insights and it was nice to see it all in one place. ... I will be recommending it to PhD students and Postdocs starting out on RSV research ... . also recommend it to people who have been working with RSV for a while to dip in and out of to fill any gaps in the general knowledge.” (John Tregoning, Immunology News, May, 2014)

Reseña del editor:

Although respiratory syncytial virus (RSV) has been a high priority for vaccine development for over 50 years now, still no vaccine is available and none has yet demonstrated sufficient promise to move to licensure. The success of RSV immune prophylaxis and the availability of ever more powerful tools to study the immune response and pathogenesis of disease, combined with the ability to construct a wide variety of vaccines using different vaccine platforms, give us grounds to believe that an RSV vaccine is within reach. This book brings together in one source what is currently known about the virus: its clinical and epidemiologic features; the host response and pathogenesis of the disease; vaccines, vaccine platforms, and treatment; and animal and tissue culture models of RSV infection. It is designed to organize the critical information relevant to RSV vaccine development, facilitate the assimilation of data, and speed progress toward producing a safe and effective vaccine.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Weitere beliebte Ausgaben desselben Titels

9783662521557: Challenges and Opportunities for Respiratory Syncytial Virus Vaccines: 372 (Current Topics in Microbiology and Immunology)

Vorgestellte Ausgabe

ISBN 10:  3662521555 ISBN 13:  9783662521557
Verlag: Springer, 2016
Softcover

Beste Suchergebnisse bei AbeBooks

Foto des Verkäufers

Verlag: Springer (2013)
ISBN 10: 364238918X ISBN 13: 9783642389184
Neu Hardcover Anzahl: 10
Anbieter:
booksXpress
(Bayonne, NJ, USA)
Bewertung

Buchbeschreibung Hardcover. Zustand: new. Bestandsnummer des Verkäufers 9783642389184

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 162,25
Währung umrechnen

In den Warenkorb

Versand: Gratis
Innerhalb der USA
Versandziele, Kosten & Dauer
Beispielbild für diese ISBN

Verlag: Springer (2014)
ISBN 10: 364238918X ISBN 13: 9783642389184
Neu Hardcover Anzahl: > 20
Anbieter:
Lucky's Textbooks
(Dallas, TX, USA)
Bewertung

Buchbeschreibung Zustand: New. Bestandsnummer des Verkäufers ABLIING23Mar3113020225746

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 172,03
Währung umrechnen

In den Warenkorb

Versand: EUR 3,73
Innerhalb der USA
Versandziele, Kosten & Dauer
Beispielbild für diese ISBN

Larry J. Anderson
Verlag: Springer (2014)
ISBN 10: 364238918X ISBN 13: 9783642389184
Neu Hardcover Anzahl: > 20
Print-on-Demand
Anbieter:
Ria Christie Collections
(Uxbridge, Vereinigtes Königreich)
Bewertung

Buchbeschreibung Zustand: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Bestandsnummer des Verkäufers ria9783642389184_lsuk

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 164,60
Währung umrechnen

In den Warenkorb

Versand: EUR 11,62
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer
Foto des Verkäufers

Barney S. Graham
ISBN 10: 364238918X ISBN 13: 9783642389184
Neu Hardcover Anzahl: 2
Print-on-Demand
Anbieter:
BuchWeltWeit Ludwig Meier e.K.
(Bergisch Gladbach, Deutschland)
Bewertung

Buchbeschreibung Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Although respiratory syncytial virus (RSV) has been a high priority for vaccine development for over 50 years now, still no vaccine is available and none has yet demonstrated sufficient promise to move to licensure. The success of RSV immune prophylaxis and the availability of ever more powerful tools to study the immune response and pathogenesis of disease, combined with the ability to construct a wide variety of vaccines using different vaccine platforms, give us grounds to believe that an RSV vaccine is within reach. This book brings together in one source what is currently known about the virus: its clinical and epidemiologic features; the host response and pathogenesis of the disease; vaccines, vaccine platforms, and treatment; and animal and tissue culture models of RSV infection. It is designed to organize the critical information relevant to RSV vaccine development, facilitate the assimilation of data, and speed progress toward producing a safe and effective vaccine. 424 pp. Englisch. Bestandsnummer des Verkäufers 9783642389184

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 160,49
Währung umrechnen

In den Warenkorb

Versand: EUR 23,00
Von Deutschland nach USA
Versandziele, Kosten & Dauer
Foto des Verkäufers

Anderson, Larry J.|Graham, Barney S.
ISBN 10: 364238918X ISBN 13: 9783642389184
Neu Hardcover Anzahl: > 20
Print-on-Demand
Anbieter:
moluna
(Greven, Deutschland)
Bewertung

Buchbeschreibung Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. A comprehensive review of the available information on RSVProvides a better understanding of RSV as prerequisite for the development of effective vaccinesWritten by leading experts in their respective fieldsAlthough respiratory s. Bestandsnummer des Verkäufers 5059129

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 136,16
Währung umrechnen

In den Warenkorb

Versand: EUR 48,99
Von Deutschland nach USA
Versandziele, Kosten & Dauer
Foto des Verkäufers

Barney S. Graham
ISBN 10: 364238918X ISBN 13: 9783642389184
Neu Hardcover Anzahl: 1
Anbieter:
AHA-BUCH GmbH
(Einbeck, Deutschland)
Bewertung

Buchbeschreibung Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Although respiratory syncytial virus (RSV) has been a high priority for vaccine development for over 50 years now, still no vaccine is available and none has yet demonstrated sufficient promise to move to licensure. The success of RSV immune prophylaxis and the availability of ever more powerful tools to study the immune response and pathogenesis of disease, combined with the ability to construct a wide variety of vaccines using different vaccine platforms, give us grounds to believe that an RSV vaccine is within reach. This book brings together in one source what is currently known about the virus: its clinical and epidemiologic features; the host response and pathogenesis of the disease; vaccines, vaccine platforms, and treatment; and animal and tissue culture models of RSV infection. It is designed to organize the critical information relevant to RSV vaccine development, facilitate the assimilation of data, and speed progress toward producing a safe and effective vaccine. Bestandsnummer des Verkäufers 9783642389184

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 164,03
Währung umrechnen

In den Warenkorb

Versand: EUR 32,99
Von Deutschland nach USA
Versandziele, Kosten & Dauer